ZANE KELLY: Open Payments
NPI 1043787526 · TALLASSEE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$426 in 20 payments from 12 companies in 2025. Trend: 2023 $714 · 2024 $1,018 · 2025 $426
Food & beverage: $426
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $206 |
| Ethicon US, LLC | 1 | $28 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $28 |
| ABBVIE INC. | 1 | $25 |
| LANTHEUS MEDICAL IMAGING, INC. | 1 | $21 |
| Novo Nordisk Inc | 1 | $19 |
| Amgen Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Medtronic, Inc. | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: AIRSUPRA, FARXIGA, DERMABOND PRINEO, XIFAXAN, VRAYLAR, DEFINITY, Rybelsus, REPATHA.
Industry payments across AL — which companies pay providers there.
